The Kærtor Foundation will govern the program by applying its own methodology.
Researchers who have submitted programs that are selected will be asked for more extensive information about the programs, which will then be evaluated in further detail. If the program is selected for prioritization, the corresponding agreements will be signed.
Incubation of the programs will begin according to the order of prioritization.
A steering committee will be set up, including the applicant biomedical research team, the Kærtor Foundation translational research team and the Janssen research team.
The Kærtor methodology will be applied. This involves evaluation and monitoring of the programs, including feasibility analysis and then progression to the advanced stages once the incubation is completed.
During this phase, Janssen, along with the other two organizations in the Johnson & Johnson group -Discovery Sciences and Johnson & Johnson Innovation- will participate in the Program Steering Committee, bringing their experience to the development of selected programs.
The start date for program incubation is in the first quarter of 2018.